0000950170-24-066771.txt : 20240530 0000950170-24-066771.hdr.sgml : 20240530 20240530171959 ACCESSION NUMBER: 0000950170-24-066771 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240529 FILED AS OF DATE: 20240530 DATE AS OF CHANGE: 20240530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOHLIN GAREN G CENTRAL INDEX KEY: 0001254705 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 241006676 MAIL ADDRESS: STREET 1: C/O PRAECIS PHARMACEUTICALS INC STREET 2: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 4 1 ownership.xml 4 X0508 4 2024-05-29 0001503802 Karyopharm Therapeutics Inc. KPTI 0001254705 BOHLIN GAREN G C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE NEWTON MA 02459 true false false false false Nonstatutory Stock Option (right to buy) 0.96 2024-05-29 4 A false 69000 0 A 2034-05-28 Common Stock 69000 69000 D This option vests as to 100% of the underlying shares on May 29, 2025. /s/ Nancy Smith, Attorney-in-Fact for Garen Bohlin 2024-05-30